Challenging Case Studies are presented by trainees or technologists. They will discuss the case's clinical history, molecular analysis, interesting features, and the proposed diagnosis. Other molecular testing methods, if applicable, will be included in the presentation, including biopsies, gross/microscopic pathology, immunohistochemistry/flow cytometry, and cytogenetic findings.
Recurrent Mediastinal Neoplasm of Unknown Origin
Jessica B. Ziemba, MD, Beth Israel Deaconess Medical Center, West Roxbury, MA, USA
Fortuitous Detection of a NUP214-ABL1 Fusion Through Copy Number Changes
Jonathan M. Tsai, MD, PhD, Brigham and Women's Hospital, Brookline, MA, USA
Targeted RNA Sequencing Reveals a Cryptic t(9;11) Leading to KMT2A-MLLT3 Fusion in Accelerated
Phase Primary Myelofibrosis Evolving into Acute Myeloid Leukemia
Audrey N. Jajosky, MD, PhD, University of Michigan, Cleveland, OH, USA
Undifferentiated Neuroblastoma with Unique Molecular Features
Sara Akhavanfard, MD, PhD, Nationwide Children's Hospital, Beachwood, OH, USA
A Compound EGFR Exon 21 Mutation in a Metastatic Liver Mass
Eric A. Goold, MD, University of Utah/ARUP laboratories, Salt Lake City, UT, USA
Objectives:
- Describe the context of a challenging clinical case.
- Discuss the molecular pathology techniques used in the diagnosis of the case.
- Propose a final diagnosis based upon findings and diagnostic evidence.
Recording Date: November 16, 2020
Continuing Education Credit Information
CME/CMLE credit: 1.00 hr
Last day to purchase course and CE claim credit: February 16, 2024
Note: Members of AMP can access this at a discount. Join the AMP Family!
All sales are final. No refunds will be issued.
No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.
